technology
As US measles cases rise, biotech firms start developing new treatments
arstechnica.com • 28 Jul 2026, 13:32
The US is making measles great again, so treatment options are needed for the most vulnerable.
Les originalartikkelen
Mere fra arstechnica.com
- Not just Neanderthals: Ghost lineage in Africa left its mark on our DNA
- Doctors took a look at man's painful shoulder—they found the joint was missing
- Google plans to exempt sanctioned nations from Android developer verification
- Reddit keeps weird DMCA lawsuit against web scraper alive despite Google’s loss